Acadia Pharmaceuticals annual gross margin
2016
2017
2018
2019
2020
2021
2022
2023
Acadia Pharmaceuticals Gross Margin Growth & History (ACAD)
Acadia Pharmaceuticals's gross margin was 94.27% for fiscal 2023.
View full Acadia Pharmaceuticals company overviewAcadia Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | 94.27% | −3.77 pp |
| 2022 | 2022-12-31 | 98.03% | +0.27 pp |
| 2021 | 2021-12-31 | 97.76% | +0.07 pp |
| 2020 | 2020-12-31 | 97.69% | +1.03 pp |
| 2019 | 2019-12-31 | 96.65% | +2.18 pp |
| 2018 | 2018-12-31 | 94.47% | +1.74 pp |
| 2017 | 2017-12-31 | 92.73% | +10.50 pp |
| 2016 | 2016-12-31 | 82.23% | — |
Acadia Pharmaceuticals quarterly gross margin
No reported data
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|
Acadia Pharmaceuticals gross margin trends
Over the last five reported fiscal years, Acadia Pharmaceuticals's gross margin decreased from 94.47% to 94.27%, a change of −0.20 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acadia Pharmaceuticals filings at SEC.gov ↗